Summit Therapeutics PLC (SMMT)

NASDAQ
6.470
-0.090(-1.37%)
  • Volume:
    151,368
  • Bid/Ask:
    6.470/6.530
  • Day's Range:
    6.460 - 6.680

SMMT Overview

Prev. Close
6.56
Day's Range
6.46-6.68
Revenue
720K
Open
6.57
52 wk Range
2.91-12.301
EPS
-0.77
Volume
151,368
Market Cap
637.92M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
232,438
P/E Ratio
-
Beta
0.64
1-Year Change
89.6%
Shares Outstanding
97,244,567
Next Earnings Date
Sep 01, 2021
What is your sentiment on Summit Therapeutics PLC?
or
Market is currently closed. Voting is open during market hours.

Summit Therapeutics PLC News

Summit Therapeutics PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellBuy
Technical IndicatorsStrong SellStrong SellSellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy

Summit Therapeutics PLC Company Profile

Summit Therapeutics PLC Company Profile

Employees
80

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. It conducts clinical programs focusing on the Clostridioides difficile infection (CDI). The company’s lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also develops DDS-01 series to treat infection caused by the bacteria Neisseria gonorrhoeae through Discuva platform; and DDS-04 series to treat Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.

Read More
  • Summit on the way up!
    0
    • what happens here ? anybody ? somebody knows ? what is this rocket ?
      0
      • interesting progress they are making in the field of vaccines.. keep the good job.
        0
        • this will be a very interesting to look at when the market opens.
          0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.